Lv11
40 积分 2025-05-15 加入
Splenic response to protein corona of nanoparticles in vivo
44分钟前
待确认
Immunotoxicity Testing for Drug: Nanoparticle Conjugates: Regulatory Considerations
4天前
已完结
Safety and signal intensity of a novel liver-specific MRI contrast agent, Orviglance® (manganese chloride tetrahydrate), in adult subjects with mild, moderate, or severe hepatic impairment
3个月前
已完结
First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer
6个月前
已完结
First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer
6个月前
已完结
皖公网安备34019202002308
